Serge Perrot1, Mariana Peixoto2, Philippe Dieudé3, Eric Hachulla4, Jerome Avouac2, Sebastien Ottaviani3, Yannick Allanore2. 1. Pain Clinic, Cochin-Hôtel Dieu Hospital, Paris Descartes University, Paris, France. serge.perrot@aphp.fr. 2. Rheumatology Department, Cochin Hospital, Paris Descartes University, Paris, France. 3. Rheumatology Department, Bichat Hospital, René Diderot University, Paris, France. 4. Internal Medicine Department, Claude Huriez Hospital, FHU Immune-Mediated Inflammatory Diseases and Targeted Therapies (IMMINeNT), Lille University, Lille France.
Abstract
OBJECTIVES: Fibromyalgia (FM) may occur with rheumatoid arthritis (RA) and systemic sclerosis (SSc), and debate remains about its diagnosis. We aimed to use three FM tools (a screening tool (FiRST), diagnostic criteria (ACR 1990 and revised 2010), to compare FM prevalence between RA and SSc patients, to describe the phenotypes of patients with comorbid FM, and to analyze links between FM and secondary Sjögren's syndrome (SS). METHODS: Consecutive adult patients with confirmed RA or SSc from four university hospitals were tested with the three FM tools. RESULTS: FiRST detected FM in 22.6% of the 172 RA patients, with confirmation in 22.1% (ACR1990) and 19.1% (ACR2010). ACR1990FM+ RA patients had more diffuse pain, whereas ACR2010FM+ RA patients had higher BMI and pain intensity, more diffuse pain, active disease, disability, and associated SS. FiRST detected FM in 27.8% of the 122 SSc patients, with confirmation in 30.3% (ACR1990) and 23.7% (ACR2010). ACR1990FM+ SSc patients had greater disability and pain intensity, and more diffuse pain, whereas ACR2010FM+ SSc patients had higher BMI, pain intensity, more disability and diffuse pain, and associated SS. Correlations between FM diagnostic and screening tool results were modest in both conditions. Secondary SS was associated with comorbid FM. CONCLUSIONS: The prevalence of FM is high in SSc and RA, whatever the FM diagnostic tool used. Secondary SS is associated with FM in both RA and SSc. The revised ACR 2010 FM criteria and FiRST screening tool reveal specific phenotypes potentially useful for improving disease management.
OBJECTIVES:Fibromyalgia (FM) may occur with rheumatoid arthritis (RA) and systemic sclerosis (SSc), and debate remains about its diagnosis. We aimed to use three FM tools (a screening tool (FiRST), diagnostic criteria (ACR 1990 and revised 2010), to compare FM prevalence between RA and SSc patients, to describe the phenotypes of patients with comorbid FM, and to analyze links between FM and secondary Sjögren's syndrome (SS). METHODS: Consecutive adult patients with confirmed RA or SSc from four university hospitals were tested with the three FM tools. RESULTS: FiRST detected FM in 22.6% of the 172 RApatients, with confirmation in 22.1% (ACR1990) and 19.1% (ACR2010). ACR1990FM+ RApatients had more diffuse pain, whereas ACR2010FM+ RApatients had higher BMI and pain intensity, more diffuse pain, active disease, disability, and associated SS. FiRST detected FM in 27.8% of the 122 SSc patients, with confirmation in 30.3% (ACR1990) and 23.7% (ACR2010). ACR1990FM+ SSc patients had greater disability and pain intensity, and more diffuse pain, whereas ACR2010FM+ SSc patients had higher BMI, pain intensity, more disability and diffuse pain, and associated SS. Correlations between FM diagnostic and screening tool results were modest in both conditions. Secondary SS was associated with comorbid FM. CONCLUSIONS: The prevalence of FM is high in SSc and RA, whatever the FM diagnostic tool used. Secondary SS is associated with FM in both RA and SSc. The revised ACR 2010 FM criteria and FiRST screening tool reveal specific phenotypes potentially useful for improving disease management.
Authors: Andreas Goebel; David Andersson; Chris Barker; Neil Basu; Craig Bullock; Stuart Bevan; Rachael J M Bashford-Rogers; Ernest Choy; David Clauw; Debra Dulake; Richard Dulake; Herta Flor; Marcia Glanvill; Zsuzsanna Helyes; Sarosh Irani; Eva Kosek; Jennifer Laird; Gary MacFarlane; Hayley McCullough; Andrew Marshall; Robert Moots; Serge Perrot; Nick Shenker; Emanuele Sher; Claudia Sommer; Camilla I Svensson; Amanda Williams; Geoff Wood; Emma R Dorris Journal: Pain Med Date: 2022-05-30 Impact factor: 3.637
Authors: Jeffrey R Curtis; Christopher Herrem; 'Matladi N Ndlovu; Cathy O'Brien; Yusuf Yazici Journal: Arthritis Res Ther Date: 2017-09-29 Impact factor: 5.156